HDE supplement

H050003 S091: RECLAIM DBS THERAPY FOR OBSESSIVE COMPULSIVE DISORDER (OCD) SYSTEM

FDA HDE supplement · 30-day notice · MEDTRONIC INC.,NEUROLOGICAL DIVISION

Key facts

Original HDE H050003
Supplement number S091
Supplement type 30-day notice
Reason for the supplement process change - manufacturer/sterilizer/packager/supplier
Trade name RECLAIM DBS THERAPY FOR OBSESSIVE COMPULSIVE DISORDER (OCD) SYSTEM
Generic name Stimulator, brain, implanted, for behavior modification
Applicant MEDTRONIC INC.,NEUROLOGICAL DIVISION
Product code MFR
Received date Sep 16, 2014
Decision date Oct 16, 2014

At a glance

  • No Approval order on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About HDE supplements

An HDE supplement asks FDA to approve a change to a Humanitarian Use Device that already holds a humanitarian device exemption.

Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date:

Browse all HDE supplements